Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $995.0000 (14.37%) ($900.0000 - $1000.0000) on Wed. Aug. 19, 2009. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 8.51% (three month average) | RSI | 57 | Latest Price | $995.0000(14.37%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 2.3% a day on average for past five trading days. | Weekly Trend | CAPR advances 0.4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) IWM(3%) PEJ(3%) XOP(3%) EWI(2%) EWP(2%) | Factors Impacting CAPR price | CAPR will decline at least -4.255% in a week (0% probabilities). IGOV(-1%) EWY(-1%) XLU(0%) XLP(0%) VWO(0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -4.255% (StdDev 8.51%) | Hourly BBV | 0 () | Intraday Trend | 10.6% | | | |
|
5 Day Moving Average | $901.01(10.43%) | 10 Day Moving Average | $876.46(13.52%) | 20 Day Moving Average | $912.89(8.99%) | To recent high | -4.8% | To recent low | 221% | Market Cap | $19.599b | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |